全球定序试剂套件市场

预计到 2030 年全球定序试剂套件市场规模将达 192 亿美元

全球定序试剂套件市场规模预计在2024年为129亿美元，预计到2030年将达到192亿美元，2024年至2030年的复合年增长率为6.9%。核酸萃取和扩增是本报告分析的细分市场之一，预计其复合年增长率为8.0%，到分析期结束时规模将达到125亿美元。文库製备细分市场在分析期间的复合年增长率预计为4.6%。

美国市场规模估计为 35 亿美元，中国市场预计复合年增长率为 11.0%

美国定序试剂套件市场规模预计2024年达到35亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到40亿美元，在2024-2030年的分析期间内，复合年增长率为11.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.3%和6.7%。在欧洲，预计德国市场的复合年增长率为4.5%。

全球「定序试剂套件」市场—主要趋势与驱动因素摘要

为什么定序试剂套件对于基因组学和精准医疗至关重要？

定序试剂套件是 DNA 和 RNA 分析工作流程中的重要组成部分，提供製备、扩增和解码遗传物质所需的试剂和通讯协定。这些套件支援广泛的应用，包括全基因组定序、标靶基因面板、表观遗传分析和总体基因体学。无论是在临床诊断、肿瘤学研究或农业生物技术领域，研究试剂套件都能简化复杂的工作流程并确保一致的结果。次世代定序仪(NGS) 的进步使这些套件变得更加重要，因为高通量平台需要高保真度、低污染的试剂才能有效处理数千个样本。此外，随着消费者基因组学、微生物组测试和感染疾病监测的兴起，定序套件不仅在精英实验室中得到应用，也在分散和照护现场环境中得到应用。它们的多功能性和在解锁遗传讯息方面的作用使它们在精准医疗时代至关重要。

文库製备和 PCR 的创新会套件的发展吗？

定序试剂套件已从基础试剂包发展为复杂的酵素优化平台。文库製备试剂套件的创新降低了输入 DNA 要求，实现了自动化，并支持碎片化或劣化的样本。无 PCR 工作流程可最大限度地减少扩增偏倚，双索引接头可在不影响准确性的情况下促进多路復用。酶的增强也缩短了反应时间，提高了特异性，并最大限度地降低了背景噪音。单细胞定序试剂套件、长读定序试剂和甲基化特异性製备试剂套件正在将该技术的覆盖范围扩展到新的生物学领域。随着研究人员寻求研究稀有变异、复杂的结构突变和细胞特异性表达模式，套件供应商正在以定制的高性能化学品来应对。预填充卡盒、冷冻干燥试剂和室温稳定形式也便于处理和运输，尤其是在现场诊断和移动实验室环境中。

法规和临床整合如何影响套件设计？

随着定序扩展到受监管的临床诊断领域，例如非侵入性产前检测 (NIPT)、肿瘤伴随诊断和病原体基因组追踪，定序试剂套件正在经历更严格的标准化和检验。开发人员目前正在开发符合 FDA、CE-IVDR 和其他国家监管要求的 IVD 级套件。这包括预先检验的工作流程、可追溯性和试剂的批间一致性。套件与定序平台共同开发，以确保端到端相容性并减少工作流程错误。与实验室资讯系统 (LIS) 和自动化液体处理器的整合对于 CLIA 认证和医院实验室也变得至关重要。此外，与报销挂钩的诊断方法正在促使开发人员提高效率并降低每个样本的成本。这些临床应用正在从研究工具转变为医疗保健工作流程中关键的、可认证的组件，从而推动更高的製造标准、更好的技术支援以及对合规性文件的关注。

是什么推动了全球定序试剂套件市场的成长？

全球定序试剂套件市场的成长受到多种因素的推动，包括基因组研究支出的增加、NGS 的临床应用以及定序化学的创新。美国、中国、英国和中东的国家基因组研究倡议的扩展正在推动对高品质、高性价比套件的需求。定序在肿瘤学、罕见疾病诊断和感染疾病监测（尤其是后 COVID）中的整合使得标准化和检验的套件对于临床实验室至关重要。学术机构、CRO 和製药公司正在扩展其基于测序的发现计划，需要一系列专用试剂组。同时，单细胞、长读和空间定序的技术进步正在突破套件性能和特异性的极限。分散式检查的扩展，特别是在兽医、农业和环境基因组学领域，正在创造对现场就绪套件的新需求。随着定序成为生物学、医学和农业的核心支柱，支持它的套件生态系统也迅速扩大。

部分

类型（核酸萃取和扩增、文库製备、对照）、技术（NGS、桑格）、应用（药物研发、肿瘤学、生殖健康、感染疾病）、最终用途（製药和生物技术、医院和诊断实验室、学术和研究、其他最终用途）

受访公司范例（总合32家）

• Agilent Technologies, Inc.
• ArcherDX, Inc.
• Beckman Coulter, Inc.
• BGI Genomics Co., Ltd.
• Bioline（a Meridian Bioscience company）
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Fluidigm Corporation
• Illumina, Inc.
• New England Biolabs, Inc.
• Oxford Nanopore Technologies
• Pacific Biosciences of California, Inc.
• PerkinElmer, Inc.
• Phase Genomics
• QIAGEN NV
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• Zymergen Inc.

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）预测公司竞争定位的变化。这种复杂且多方面的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Sequencing Kits Market to Reach US$19.2 Billion by 2030

The global market for Sequencing Kits estimated at US$12.9 Billion in the year 2024, is expected to reach US$19.2 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Nucleic Acid Extraction & Amplification, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$12.5 Billion by the end of the analysis period. Growth in the Library Preparation segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.5 Billion While China is Forecast to Grow at 11.0% CAGR

The Sequencing Kits market in the U.S. is estimated at US$3.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.0 Billion by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global "Sequencing Kits" Market - Key Trends & Drivers Summarized

Why Are Sequencing Kits Central to Genomics and Precision Medicine?

Sequencing kits are essential components in DNA and RNA analysis workflows, providing the reagents and protocols needed to prepare, amplify, and decode genetic material. These kits support a wide range of applications including whole genome sequencing, targeted gene panels, epigenetic profiling, and metagenomics. Whether used in clinical diagnostics, oncology research, or agricultural biotechnology, sequencing kits streamline complex workflows and ensure consistent results. Advances in next-generation sequencing (NGS) have made these kits even more critical, as higher throughput platforms require high-fidelity, low-contamination reagents to process thousands of samples efficiently. Additionally, with the rise of consumer genomics, microbiome testing, and infectious disease surveillance, sequencing kits are now used not only in elite research labs but also in decentralized and point-of-care settings. Their versatility and role in unlocking genetic information make them indispensable in the era of precision medicine.

Are Innovations in Library Prep and PCR Driving Kit Evolution?

Sequencing kits have evolved beyond basic reagent bundles into sophisticated, enzyme-optimized platforms. Innovations in library preparation kits have reduced input DNA requirements, enabled automation, and supported fragmented or degraded samples. PCR-free workflows are now available to minimize amplification bias, while dual-index adapters enhance multiplexing without compromising accuracy. Enzyme enhancements have also reduced reaction times, increased specificity, and minimized background noise. Single-cell sequencing kits, long-read sequencing reagents, and methylation-specific prep kits are expanding the technology’s reach into new biological domains. As researchers seek to study rare variants, complex structural variations, and cell-specific expression patterns, kit providers are responding with tailored, high-performance chemistry. Pre-loaded cartridges, lyophilized reagents, and room-temperature-stable formats are also enabling easier handling and shipping, especially in field diagnostics and mobile lab environments.

How Are Regulation and Clinical Integration Reshaping Kit Design?

As sequencing expands into regulated clinical diagnostics-such as non-invasive prenatal testing (NIPT), oncology companion diagnostics, and pathogen genome tracing-sequencing kits are undergoing stricter standardization and validation. Manufacturers are now developing IVD-grade kits compliant with FDA, CE-IVDR, and other national regulatory requirements. This includes pre-validated workflows, traceability, and lot-to-lot consistency in reagents. Kits are being co-developed with sequencing platforms to ensure end-to-end compatibility and reduce workflow errors. Integration with laboratory information systems (LIS) and automated liquid handlers is also becoming critical for CLIA-certified and hospital-based labs. Furthermore, reimbursement-linked diagnostics are pressuring developers to improve efficiency and reduce cost per sample. These clinical applications are transforming sequencing kits from research tools into critical, certifiable components of medical workflows, prompting higher manufacturing standards, better technical support, and increased focus on compliance documentation.

What’s Fueling Global Growth in the Sequencing Kits Market?

The growth in the global sequencing kits market is driven by several factors including rising genomic research funding, clinical adoption of NGS, and innovations in sequencing chemistry. Expanding national genomics initiatives across the U.S., China, UK, and Middle East are generating bulk demand for high-quality, cost-efficient kits. The integration of sequencing in oncology, rare disease diagnosis, and infectious disease surveillance-particularly post-COVID-has made standardized, validated kits essential for clinical labs. Academic institutions, CROs, and pharma companies are scaling up sequencing-based discovery programs, requiring a range of specialized reagent kits. Meanwhile, technological advancements in single-cell, long-read, and spatial sequencing are pushing the limits of kit performance and specificity. Growth of decentralized testing, especially in veterinary, agricultural, and environmental genomics, is creating new demand for field-compatible kits. As sequencing becomes a core pillar of biology, medicine, and agriculture, the supporting kit ecosystem is expanding rapidly to keep pace.

SCOPE OF STUDY:

The report analyzes the Sequencing Kits market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Nucleic Acid Extraction & Amplification, Library Preparation, Control); Technology (NGS, Sanger); Application (Drug Discovery, Oncology, Reproductive Health, Infectious Diseases); End-Use (Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Agilent Technologies, Inc.
• ArcherDX, Inc.
• Beckman Coulter, Inc.
• BGI Genomics Co., Ltd.
• Bioline (a Meridian Bioscience company)
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Fluidigm Corporation
• Illumina, Inc.
• New England Biolabs, Inc.
• Oxford Nanopore Technologies
• Pacific Biosciences of California, Inc.
• PerkinElmer, Inc.
• Phase Genomics
• QIAGEN N.V.
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• Zymergen Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Sequencing Kits - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Widespread Adoption of Precision Medicine and Genomics Propels Growth in Sequencing Kit Demand
  • Rapid Decline in NGS Costs Expands Access and Drives Use of Sequencing Kits Across Research and Clinical Settings
  • Increased Focus on Infectious Disease Surveillance and Pathogen Genotyping Strengthens Business Case for Rapid Kits
  • Surge in Genetic Testing for Ancestry and Wellness Drives Consumer-Focused Sequencing Kit Innovations
  • Advancements in Single-Cell Sequencing Technologies Accelerate Need for High-Fidelity, Low-Input Kits
  • Regulatory Push for Companion Diagnostics and Targeted Therapies Expands Market for Clinical-Grade Sequencing Kits
  • Growing Cancer Genomics Programs Globally Spurs Demand for Oncology-Specific Sequencing Solutions
  • Automation in Laboratory Workflows Drives Adoption of Pre-Configured and Ready-to-Use Sequencing Kits
  • Expansion of Biobanking and Population Genomics Initiatives Creates New Opportunities for Large-Scale Sequencing
  • Rise in Agricultural Genomics and CRISPR Research Sustains Demand for High-Throughput Sequencing Kits
  • Strategic Collaborations Between Biotech and Diagnostic Companies Generate Pipeline for Custom Sequencing Kits
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Sequencing Kits Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Sequencing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Sequencing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Sequencing Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Nucleic Acid Extraction & Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Nucleic Acid Extraction & Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Nucleic Acid Extraction & Amplification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Control by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Pharmaceutical & Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Pharmaceutical & Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospital & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for NGS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Sanger by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Sanger by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Sanger by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Reproductive Health by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• JAPAN
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• CHINA
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 80: China Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• EUROPE
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Sequencing Kits by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Sequencing Kits by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Sequencing Kits by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• FRANCE
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 107: France Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• GERMANY
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Italy 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 143: UK Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: UK 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Spain 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Russia 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Sequencing Kits by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Sequencing Kits by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Australia 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• INDIA
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 218: India Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: India 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: South Korea 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Sequencing Kits by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Sequencing Kits by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Argentina 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Brazil 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Mexico 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Sequencing Kits by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Sequencing Kits by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Iran 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Israel 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: UAE 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• AFRICA
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Africa 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030

IV. COMPETITION